等待开盘 10-04 09:30:00 美东时间
+0.060
+0.20%
The proportion of U.S. employers offering coverage for GLP-1 drugs for both diabetes and weight loss has sharply increased over the past six months amid new FDA approvals, a new survey conducted by th...
2024-06-14 20:01